• Aging : Aging (Albany NY) (by Medline/PubMed), Aging-US (by Web of Science)

    Impact factor (IF2018): 5.515

    Aging publishes research papers in all fields of aging research including but not limited, aging from yeast to mammals, cellular senescence, age-related diseases such as cancer and Alzheimer’s diseases and their prevention and treatment, anti-aging strategies and drug development and especially the role of signal transduction pathways such as mTOR in aging and potential approaches to modulate these signaling pathways to extend lifespan.

    The journal aims to promote treatment of age-related diseases by slowing down aging, validation of anti-aging drugs by treating age-related diseases, prevention of cancer by inhibiting aging. Cancer and COVID-19 are age-related diseases.

    Papers of Nobel winners in Physiology&Medicine: Elizabeth Blackburn (6 papers), Andrew V. Schally, and Shinya Yamanaka.

    National Cancer Institute Director Norman E. “Ned” Sharpless, M.D., a member of the Editorial Board of Aging, will serve as FDA acting commissioner, HHS Secretary Alex Azar announced at a congressional hearing on March 12, 2019.
    Aging is indexed by PubMed/Medline abbreviated as “Aging (Albany NY), PubMed Central, ISI/Web of Science: Science Citation Index Expanded (abbreviated as Aging‑US and listed in the Cell Biology category; since June 2017 it has also been listed in the Geriatrics & Gerontology category), and Scopus /Rank Q1 (abbreviated as Aging).
    Impact Journals, LLC meets the Wellcome Trust Publisher Requirements, and is now a member of the Wellcome Trust List of Compliant Publishers.
    Impact Journals, LLC is a member of the Society for Scholarly Publishing.

Cover Volume 12, Issue 10